In This Article:
Align Technology, Inc. ALGN recently made its Invisalign System with mandibular advancement featuring occlusal blocks commercially available. It is designed for Class II skeletal and dental correction with simultaneous teeth alignment.
The latest clinical innovation is expected to expand Align Technology’s Class II treatment portfolio for kids and teenage patients, offering practitioners a comprehensive solution.
ALGN Stock’s Likely Trend Following the News
After the announcement, shares of ALGN increased 3.1% at the after-market trading session yesterday.
Align Technology is strategically capturing the growing malocclusion market, one of the most prevalent clinical dental conditions in the world. The Invisalign System with mandibular advancement featuring occlusal blocks reflects the company’s continued commitment to expanding the capabilities of the Invisalign System. This enables doctors to treat a wider range of malocclusions with precision and efficiency and helps continue advancing clear aligners as the standard of care in digital orthodontics. Accordingly, we expect the market sentiment toward ALGN stock to remain positive surrounding the news.
Align Technology has a market capitalization of $11.63 billion. Going by the Zacks Consensus Estimate, the company’s 2025 revenues will increase 2.3%. In the trailing four quarters, it delivered an average earnings beat of 3.53%.
About ALGN’s Invisalign System With Mandibular Advancement
This innovative solution is the company’s first clear aligner product with integrated solid occlusal blocks that deliver predictable mandibular advancement. Invisalign occlusal blocks offer durability, enhance engagement, and enable vertical opening, allowing for earlier mandibular advancement in cases such as Class II deep bite, thereby improving treatment efficiency.
For investors’ note, Class II malocclusion is one of the most common orthodontic problems, characterized by a discrepancy in jaw alignment. This condition can lead to functional, aesthetic, and other challenges for patients if left untreated.
The system is primarily intended for growing patients in the late mixed or early permanent dentition stages (ages 10-16) who are still experiencing growth. It is made from patented SmartTrack material, which elevates patient comfort and compliance. By combining SmartTrack material, SmartForce features and SmartStage technology, it offers predictable tooth movement.
Image Source: Zacks Investment Research
This clear aligner product with integrated solid occlusal blocks is now commercially available to invisalign-trained doctors in Australia and New Zealand. Also, it is available on a limited market release in North America, and most EMEA countries. It will likely be introduced in additional markets throughout 2025.